Comparison Chart Seelos Therapeutics, Inc.
Stocks
SEEL.Q
US81577F4063
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | +9,900.00% |
|
0.00% | - |
| 12-29 | Motion for Asset Sale Approved for Seelos Therapeutics, Inc. | CI |
| 21/10/25 | GLD Partners, LP acquired Select assets from Seelos Therapeutics, Inc. (OTCPK : SEEL.Q). | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SEELOS THERAPEUTICS, INC. | Bio Therapeutic Drugs | +9,900.00% | 0.00% | - | - | -100.00% | 136 |
-
|
-
|
-
|
- Stock Market
- Stocks
- SEEL.Q Stock
- Charts Seelos Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
